Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Laureate Signs Bio-Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News

Laureate Signs Bio-Pact

Laureate Pharma has signed a biopharma development and manufacturing agreement with an undisclosed client

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Laureate Pharma has signed a biopharmaceutical development and manufacturing agreement with an undisclosed client. Laureate will develop the process to manufacture a unique Fc Fusion Protein and produce it under cGMP conditions for use in clinical trials. Terms of the agreement were not disclosed.

“This project is a great fit with the experience that we have developed over the past few years working with fusion proteins,” said Robert J. Broeze, Ph. D., president and chief executive officer of Laureate Pharma. “We have had great success working with these unique protein products and are delighted to have the opportunity to help advance this product into the clinic.”

“We are seeing a strong trend in the biopharmaceutical industry to develop fusion protein products with unique properties,” commented Dan Leone, Laureate’s vice president, business development. “Along with monoclonal antibodies, manufacturing fusion proteins has become one of Laureate’s core competencies.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics